Chromosomal imbalances in oral squamous cell carcinoma: examination of 31 cell lines and review of the literature.
暂无分享,去创建一个
Thomas Ried | Christa Lese Martin | C. Martin | T. Ried | S. Gollin | Jonas T Johnson | John W. Wilson | E. Myers | S. Reshmi | John W Wilson | Susanne M Gollin | Shalini C Reshmi | William Gottberg | Jaya K Reddy | Poornima Khanna | Eugene N Myers | Jonas T. Johnson | Jaya K. Reddy | William Gottberg | Poornima Khanna
[1] A. Neugut,et al. A comparison of the clinical characteristics of first and second primary head and neck cancers. A population‐based study , 1991, Cancer.
[2] R. Day,et al. Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival , 1998 .
[3] W. Hong,et al. Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification , 1998, Oncogene.
[4] P. Platzer,et al. Microenvironmental genomic alterations and clinicopathological behavior in head and neck squamous cell carcinoma. , 2007, JAMA.
[5] J. Wilson,et al. Cyclins, cyclin-dependent kinases, cyclin-dependent kinase inhibitors and their role in head and neck cancer. , 1998, Clinical otolaryngology and allied sciences.
[6] Irene L Andrulis,et al. MADR2 Maps to 18q21 and Encodes a TGFβ–Regulated MAD–Related Protein That Is Functionally Mutated in Colorectal Carcinoma , 1996, Cell.
[7] B. Tilley,et al. Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region , 1994, Genes, chromosomes & cancer.
[8] T. Nakashima,et al. Identification and cDNA cloning of headpin, a novel differentially expressed serpin that maps to chromosome 18q. , 1999, Biochemical and biophysical research communications.
[9] S. Gollin,et al. Visualization of INT2 and HST1 Amplification in oral squamous cell carcinomas , 1995, Genes, chromosomes & cancer.
[10] K. Tanimoto,et al. Abnormalities of the FHIT gene in human oral carcinogenesis , 2000, British Journal of Cancer.
[11] J. Fridlyand,et al. Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma , 2005, Oncogene.
[12] A. Jemal,et al. Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.
[13] T. Nakashima,et al. Genomic cloning, mapping, structure and promoter analysis of HEADPIN, a serpin which is down-regulated in head and neck cancer cells. , 2000, Biochimica et biophysica acta.
[15] I. Petersen,et al. Chromosomal instability and cytoskeletal defects in oral cancer cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[16] J. Batsakis,et al. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma. , 1995, Cancer research.
[17] Iscn. International System for Human Cytogenetic Nomenclature , 1978 .
[18] S. Gollin,et al. Relationship between FRA11F and 11q13 gene amplification in oral cancer , 2007, Genes, chromosomes & cancer.
[19] P. Lichter,et al. Candidate genes in breast cancer revealed by microarray-based comparative genomic hybridization of archived tissue. , 2005, Cancer research.
[20] M. Hendrix,et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. , 1994, Science.
[21] A. Read,et al. Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma of the oral cavity. , 1994, Cancer research.
[22] G. Pruneri,et al. Molecular and immunohistochemical analysis of the bcl‐1/cyclin D1 gene in laryngeal squamous cell carcinomas , 1997, Cancer.
[23] T. Godfrey,et al. Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma , 2006, Genes, chromosomes & cancer.
[24] Xin Huang,et al. High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[25] F. Bosch,et al. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. , 1994, Cancer research.
[26] S. Leeder,et al. A population based study , 1993, The Medical journal of Australia.
[27] F. Mitelman,et al. Nonrandom chromosome abnormalities in short-term cultured primary squamous cell carcinomas of the head and neck. , 1995, Cancer research.
[28] C. Croce,et al. FHIT gene alterations in head and neck squamous cell carcinomas. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[29] S. Gollin,et al. Chromosomal instability and marker chromosome evolution in oral squamous cell carcinoma , 2004, Genes, chromosomes & cancer.
[30] J. Stephenson,et al. Murine leukemia virus mutants with temperature-sensitive defects in precursor polypeptide cleavage , 1975, Cell.
[31] F. Mertens,et al. Cytogenetic abnormalities in 106 oral squamous cell carcinomas. , 2006, Cancer genetics and cytogenetics.
[32] F. Mitelman,et al. Chromosomal abnormalities involving 11q13 are associated with poor prognosis in patients with squamous cell carcinoma of the head and neck , 1995, Cancer.
[33] J. Shah,et al. Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] F. Mertens,et al. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression , 1997, Cancer.
[35] L. Goodrich,et al. Duplication of ATR inhibits MyoD, induces aneuploidy and eliminates radiation-induced G1 arrest , 1998, Nature Genetics.
[36] R. Hruban,et al. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. , 1994, Cancer research.
[37] J. Califano,et al. 11:40 AM: A Genetic Progression Model for Head and Neck Cancer: Implications for Field Cancerization , 1996 .
[38] J. Grandis,et al. Head and neck squamous cell carcinoma cell lines: Established models and rationale for selection , 2007, Head & neck.
[39] T. Ried,et al. H2AX Haploinsufficiency Modifies Genomic Stability and Tumor Susceptibility , 2003, Cell.
[40] C. R. Leemans,et al. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. , 2003, Cancer research.
[41] M. Oshimura,et al. Functional evidence for involvement of multiple putative tumor suppressor genes on the short arm of chromosome 3 in human oral squamous cell carcinogenesis. , 1998, Cancer genetics and cytogenetics.
[42] M. Welters,et al. Centromeric breakage as a major cause of cytogenetic abnormalities in oral squamous cell carcinoma , 1996, Genes, chromosomes & cancer.
[43] P. Lichter,et al. Recurrent coamplification of cytoskeleton‐associated genes EMS1 and SHANK2 with CCND1 in oral squamous cell carcinoma , 2006, Genes, chromosomes & cancer.
[44] P. Mieczkowski,et al. The Pattern of Gene Amplification Is Determined by the Chromosomal Location of Hairpin-Capped Breaks , 2006, Cell.
[45] T. Carey,et al. Loss of chromosome arm 18q with tumor progression in head and neck squamous cancer , 2004, Genes, chromosomes & cancer.
[46] D. Ward,et al. Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. , 1995, Cancer research.
[47] A. Hart,et al. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. , 1995, Cancer research.
[48] M. L. Le Beau,et al. A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage‐fusion‐bridge cycle model for 11q13 amplification , 2000, Genes, chromosomes & cancer.
[49] F. Latif,et al. Detailed genetic and physical map of the 3p chromosome region surrounding the familial renal cell carcinoma chromosome translocation, t(3;8)(p14.2;q24.1). , 1993, Cancer research.
[50] T. Gilmer,et al. Oncogene amplification in squamous cell carcinoma of the head and neck. , 1990, Archives of otolaryngology--head & neck surgery.
[51] K. Somers,et al. Amplification of the int-2 gene in human head and neck squamous cell carcinomas. , 1990, Oncogene.
[52] I. Bièche,et al. Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancer. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[53] R. Weichselbaum,et al. Cytogenetic evidence of the multistep origin of head and neck squamous cell carcinomas. , 1992, Journal of the National Cancer Institute.
[54] S. Gollin. Chromosomal alterations in squamous cell carcinomas of the head and neck: Window to the biology of disease , 2001, Head & neck.
[55] David I. Smith,et al. A role for common fragile site induction in amplification of human oncogenes. , 2002, Cancer cell.
[56] F. Mertens,et al. Chromosome abnormalities in oral squamous cell carcinomas. , 1993, European journal of cancer. Part B, Oral oncology.
[57] K. Hörmann,et al. Fhit expression is absent or reduced in a subset of primary head and neck cancer. , 2000, Anticancer Research.
[58] Jorma Isola,et al. Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization. , 2003, Cancer research.
[59] J. Jen,et al. AIS is an oncogene amplified in squamous cell carcinoma. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[60] T. Glover,et al. Mechanisms of common fragile site instability. , 2005, Human molecular genetics.
[61] Scott E. Kern,et al. DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.
[62] Lesley Seymour,et al. Erlotinib in lung cancer - molecular and clinical predictors of outcome. , 2005, The New England journal of medicine.
[63] H. Moch,et al. Tissue microarrays for gene amplification surveys in many different tumor types. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[64] O. Kallioniemi,et al. Identification of target genes in laryngeal squamous cell carcinoma by high-resolution copy number and gene expression microarray analyses , 2006, Oncogene.
[65] Kathleen R. Cho,et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. , 1990, Science.
[66] R. Ferrell,et al. Loss of heterozygosity of the short arm of chromosomes 3 and 9 in oral cancer , 1996, International journal of cancer.
[67] V. Wreesmann,et al. Chromosomal aberrations in squamous cell carcinomas of the upper aerodigestive tract: biologic insights and clinical opportunities. , 2005, Journal of Oral Pathology & Medicine.
[68] E. Schuuring,et al. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. , 1992, Oncogene.
[69] R. Zarbo,et al. Chromosomal aberrations identified in culture of squamous carcinomas are confirmed by fluorescence in situ hybridisation. , 1999, Molecular pathology : MP.
[70] F. Alt,et al. Histone H2AX A Dosage-Dependent Suppressor of Oncogenic Translocations and Tumors , 2003, Cell.
[71] S. Gollin. Mechanisms leading to chromosomal instability. , 2005, Seminars in cancer biology.
[72] R. Maestro,et al. Three discrete regions of deletion at 3p in head and neck cancers. , 1993, Cancer research.
[73] Amplification and expression of EMS-1 (cortactin) in head and neck squamous cell carcinoma cell lines. , 1996, Oncogene.
[74] Mattias Höglund,et al. Frequent amplification of 8q24, 11q, 17q, and 20q‐specific genes in pancreatic cancer , 2002, Genes, chromosomes & cancer.
[75] A. Bernheim,et al. Initiation of the breakage-fusion-bridge mechanism through common fragile site activation in human breast cancer cells: the model of PIP gene duplication from a break at FRA7I. , 2002, Human molecular genetics.
[76] M. Romkes,et al. Loss of distal 11q is associated with DNA repair deficiency and reduced sensitivity to ionizing radiation in head and neck squamous cell carcinoma , 2007, Genes, chromosomes & cancer.
[77] M. Höglund,et al. FISH characterization of head and neck carcinomas reveals that amplification of band 11q13 is associated with deletion of distal 11q , 1998, Genes, chromosomes & cancer.
[78] W. Lam,et al. 3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites. , 2002, Cancer research.
[79] A. Read,et al. Allelic imbalance on chromosome 3p in oral dysplastic lesions: an early event in oral carcinogenesis. , 1996, Cancer research.
[80] I. Petersen,et al. Chromosomal alterations during metastasis formation of head and neck squamous cell carcinoma , 2002, Genes, chromosomes & cancer.
[81] D. Gordenin,et al. The Mre11 Complex Is Required for Repair of Hairpin-Capped Double-Strand Breaks and Prevention of Chromosome Rearrangements , 2002, Cell.
[82] K. Kok,et al. High-resolution mapping identifies a commonly amplified 11q13.3 region containing multiple genes flanked by segmental duplications , 2007, Human Genetics.
[83] B. Houle,et al. Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[84] C. Martin,et al. The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines. , 2007, Oral oncology.
[85] G. Kong,et al. Comparative genomic hybridization analysis reveals 3q gain resulting in genetic alteration in 3q in advanced oral squamous cell carcinoma. , 2001, Cancer genetics and cytogenetics.
[86] T. Carey,et al. Nonrandom chromosome aberrations and clonal populations in head and neck cancer. , 1993, Anticancer research.
[87] A. Jemal,et al. Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.
[88] E. Feingold,et al. Inverted duplication pattern in anaphase bridges confirms the breakage-fusion-bridge (BFB) cycle model for 11q13 amplification , 2007, Cytogenetic and Genome Research.
[89] T. Glover,et al. Positional cloning of the hereditary renal carcinoma 3;8 chromosome translocation breakpoint. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[90] J. Yokota,et al. Human HST1 (HSTF1) gene maps to chromosome band 11q13 and coamplifies with the INT2 gene in human cancer. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[91] J W Gray,et al. Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[92] G. Silverman,et al. A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[93] D. Gisselsson,et al. Molecular cytogenetic characterization of the 11q13 amplicon in head and neck squamous cell carcinoma , 2006, Cytogenetic and Genome Research.
[94] D. Albertson,et al. Chromosome aberrations in solid tumors , 2003, Nature Genetics.
[95] D. Horsfall,et al. EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer , 1997, Oncogene.
[96] M R Speicher,et al. Quantitative analysis of comparative genomic hybridization. , 1995, Cytometry.
[97] Thomas Cremer,et al. Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization , 1993, Human Genetics.
[98] Alejandro A Schäffer,et al. Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression , 2002, Genes, chromosomes & cancer.
[99] A. Hart,et al. Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. , 1997, Archives of otolaryngology--head & neck surgery.